ACLARION, INC. Capital Expenditures
ACLARION, INC. (ACON) reported Capital Expenditures of $1.81 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- ACLARION, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $13.73K, a 168.35% increase year-over-year.
- ACLARION, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $7.32K.
- ACLARION, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $5.12K.
- ACLARION, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $0.00.
- ACLARION, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $21.53K, a 320.88% increase from fiscal 2024.
- ACLARION, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $5.12K.
- ACLARION, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $0.00.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.81K 10-Q · filed 2026-08-06 | ||||
| 2025-12-31 | $13.73K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $21.05K derived: sum of 2 quarters · filed 2026-03-18 | $21.53K 10-K · filed 2026-03-18 | ||
| 2025-09-30 | $7.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $7.80K 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | $480.00 10-Q · filed 2026-08-06 | $481.00 10-Q · filed 2025-08-14 | |||
| 2024-12-31 | $5.12K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $5.12K derived: sum of 2 quarters · filed 2026-03-18 | $5.12K 10-K · filed 2026-03-18 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-04-09 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |